Recently, fortilin levels in blood were reported to be elevated in patients with malignant tumors, including colorectal and lung cancers [1,4,16], and blood fortilin levels were suggested to be a promising biomarker for apoptosis [8]. This evidence concerns the gene TPT1 and lung carcinoma.